Crinetics Pharmaceuticals (CRNX) Other Non Operating Income (2024 - 2026)

Crinetics Pharmaceuticals' Other Non Operating Income history runs 3 years deep, the most recent figure standing at -$131000.0 for Q1 2026.

• In Q1 2026, Other Non Operating Income rose 35.47% year-over-year to -$131000.0; the TTM figure through Mar 2026 stood at -$508000.0 (changed N/A YoY), while the FY2025 annual figure was -$357000.0, up 31.21% from the prior year.
• Other Non Operating Income for Q1 2026 stood at -$131000.0, down from -$125000.0 in the prior quarter.
• The five-year high for Other Non Operating Income was -$37000.0 in Q3 2024, with the low at -$218000.0 in Q4 2024.
• The 3-year median for Other Non Operating Income is -$128000.0 (2025), against an average of -$127166.7.
• Peak annual rise in Other Non Operating Income reached 42.66% in 2025, while the deepest fall reached 32.43% in 2025.
• Crinetics Pharmaceuticals' Other Non Operating Income stood at -$218000.0 in 2024, then soared by 42.66% to -$125000.0 in 2025, then declined by 4.8% to -$131000.0 in 2026.
• Business Quant data shows CRNX's Other Non Operating Income at -$131000.0 in Q1 2026, -$125000.0 in Q4 2025, and -$49000.0 in Q3 2025.